. Primary outcome analysis of the multicentre phase II trial of 18F-flutemetamol, a Pittsburgh Compound B derivative for in vivo beta amyloid imaging. Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Toronto: HAI Amyloid Imaging Conference Abstracts